tiprankstipranks
Trending News
More News >
Aspen Pharmacare Holdings Limited (APNHF)
OTHER OTC:APNHF
US Market

Aspen Pharmacare Holdings (APNHF) Ratios

Compare
16 Followers

Aspen Pharmacare Holdings Ratios

APNHF's free cash flow for Q4 2025 was Rs0.41. For the 2025 fiscal year, APNHF's free cash flow was decreased by Rs and operating cash flow was Rs-0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.21 2.21 1.81 1.92 1.48
Quick Ratio
1.18 1.18 1.07 1.08 0.80
Cash Ratio
0.37 0.37 0.51 0.47 0.26
Solvency Ratio
0.02 >-0.01 0.12 0.15 0.20
Operating Cash Flow Ratio
0.29 0.29 0.26 0.24 0.23
Short-Term Operating Cash Flow Coverage
1.12 1.12 0.56 0.71 0.47
Net Current Asset Value
Rs -12.30BRs -12.30BRs -10.21BRs -3.55BRs -5.87B
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.27 0.26 0.22 0.20
Debt-to-Equity Ratio
0.43 0.43 0.43 0.34 0.31
Debt-to-Capital Ratio
0.30 0.30 0.30 0.25 0.24
Long-Term Debt-to-Capital Ratio
0.27 0.27 0.23 0.20 0.13
Financial Leverage Ratio
1.60 1.60 1.64 1.56 1.57
Debt Service Coverage Ratio
0.29 0.19 0.65 0.92 0.73
Interest Coverage Ratio
4.76 0.87 3.14 5.91 11.33
Debt to Market Cap
0.72 0.63 0.36 0.38 0.36
Interest Debt Per Share
85.18 85.07 87.08 68.90 50.80
Net Debt to EBITDA
10.66 13.75 2.43 1.90 1.51
Profitability Margins
Gross Profit Margin
44.11%44.11%43.52%45.22%47.42%
EBIT Margin
1.61%3.52%17.76%19.35%23.05%
EBITDA Margin
6.43%4.98%22.18%23.75%27.49%
Operating Profit Margin
18.76%3.31%15.65%19.21%22.46%
Pretax Profit Margin
-0.28%-0.28%12.78%16.10%21.07%
Net Profit Margin
-2.50%-2.50%9.85%12.84%16.81%
Continuous Operations Profit Margin
-2.50%-2.50%9.85%12.84%16.81%
Net Income Per EBT
880.49%880.49%77.07%79.76%79.76%
EBT Per EBIT
-1.51%-8.56%81.65%83.80%93.81%
Return on Assets (ROA)
-0.80%-0.80%3.16%3.89%5.83%
Return on Equity (ROE)
-1.27%-1.28%5.19%6.06%9.15%
Return on Capital Employed (ROCE)
6.87%1.21%6.10%7.04%9.86%
Return on Invested Capital (ROIC)
58.24%1.17%4.28%5.24%6.94%
Return on Tangible Assets
-1.71%-1.71%6.47%7.97%12.31%
Earnings Yield
-2.17%-1.90%4.48%6.80%10.74%
Efficiency Ratios
Receivables Turnover
3.25 3.25 3.90 4.04 4.68
Payables Turnover
2.27 2.27 5.78 5.62 5.58
Inventory Turnover
1.35 1.35 1.40 1.14 1.29
Fixed Asset Turnover
2.00 2.00 2.18 2.15 2.38
Asset Turnover
0.32 0.32 0.32 0.30 0.35
Working Capital Turnover Ratio
1.95 2.12 2.18 2.50 10.84
Cash Conversion Cycle
222.74 222.74 290.62 346.37 295.89
Days of Sales Outstanding
112.28 112.28 93.61 90.44 77.93
Days of Inventory Outstanding
271.24 271.24 260.21 320.89 283.42
Days of Payables Outstanding
160.78 160.78 63.19 64.96 65.47
Operating Cycle
383.52 383.52 353.81 411.33 361.36
Cash Flow Ratios
Operating Cash Flow Per Share
11.62 11.62 14.01 12.43 11.86
Free Cash Flow Per Share
5.82 0.23 1.55 5.27 5.91
CapEx Per Share
5.80 11.39 12.46 7.16 5.95
Free Cash Flow to Operating Cash Flow
0.50 0.02 0.11 0.42 0.50
Dividend Paid and CapEx Coverage Ratio
1.24 0.78 0.88 1.19 1.38
Capital Expenditure Coverage Ratio
2.00 1.02 1.12 1.74 1.99
Operating Cash Flow Coverage Ratio
0.14 0.14 0.17 0.19 0.24
Operating Cash Flow to Sales Ratio
0.12 0.12 0.14 0.14 0.14
Free Cash Flow Yield
5.17%0.18%0.70%3.04%4.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-46.15 -52.53 22.33 14.70 9.31
Price-to-Sales (P/S) Ratio
1.15 1.31 2.20 1.89 1.56
Price-to-Book (P/B) Ratio
0.59 0.67 1.16 0.89 0.85
Price-to-Free Cash Flow (P/FCF) Ratio
19.35 547.07 142.53 32.86 22.57
Price-to-Operating Cash Flow Ratio
9.69 11.03 15.80 13.92 11.24
Price-to-Earnings Growth (PEG) Ratio
0.37 0.42 -1.41 -0.83 0.26
Price-to-Fair Value
0.59 0.67 1.16 0.89 0.85
Enterprise Value Multiple
28.59 40.08 12.35 9.85 7.21
Enterprise Value
79.69B 86.61B 122.46B 95.23B 76.47B
EV to EBITDA
28.59 40.08 12.35 9.85 7.21
EV to Sales
1.84 2.00 2.74 2.34 1.98
EV to Free Cash Flow
30.85 832.75 177.49 40.71 28.57
EV to Operating Cash Flow
15.45 16.79 19.67 17.25 14.23
Tangible Book Value Per Share
28.10 28.11 31.11 39.48 27.12
Shareholders’ Equity Per Share
191.16 191.20 191.03 194.14 156.60
Tax and Other Ratios
Effective Tax Rate
-7.80 -7.80 0.23 0.20 0.20
Revenue Per Share
97.64 97.66 100.64 91.65 85.22
Net Income Per Share
-2.44 -2.44 9.91 11.77 14.32
Tax Burden
8.80 8.80 0.77 0.80 0.80
Interest Burden
-0.18 -0.08 0.72 0.83 0.91
Research & Development to Revenue
0.00 0.00 <0.01 <0.01 0.01
SG&A to Revenue
0.09 0.09 0.08 0.04 0.04
Stock-Based Compensation to Revenue
0.00 0.00 <0.01 <0.01 <0.01
Income Quality
-4.76 3.59 0.89 0.71 0.62
Currency in ZAR